 | • レポートコード：GIR-2104Z14027 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、トキソプラズマ症検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。トキソプラズマ症検査の種類別市場規模（試験装置、試薬消耗品）、用途別市場規模（病院、商業・私立研究所、医師オフィス）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・トキソプラズマ症検査の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Laboratories、Affymetrix、Bio-Rad Laboratories、Beckman Coulter、Biomerica、Cepheid、Biotest、GenBio ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：試験装置、試薬消耗品 ・用途別分析2016年-2026年：病院、商業・私立研究所、医師オフィス ・トキソプラズマ症検査の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・トキソプラズマ症検査のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・トキソプラズマ症検査のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・トキソプラズマ症検査の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・トキソプラズマ症検査の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Toxoplasmosis Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Toxoplasmosis Testing size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Toxoplasmosis Testing market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Toxoplasmosis Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Testing Equipment
Reagent Consumables
Market segment by Application, can be divided into
Hospitals
Commercial Or Private Laboratories
Physician Offices
Market segment by players, this report covers
Abbott Laboratories
Affymetrix
Bio-Rad Laboratories
Beckman Coulter
Biomerica
Cepheid
Biotest
GenBio
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Toxoplasmosis Testing
1.2 Classification of Toxoplasmosis Testing by Type
1.2.1 Overview: Global Toxoplasmosis Testing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Toxoplasmosis Testing Revenue Market Share by Type in 2020
1.2.3 Testing Equipment
1.2.4 Reagent Consumables
1.3 Global Toxoplasmosis Testing Market by Application
1.3.1 Overview: Global Toxoplasmosis Testing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Commercial Or Private Laboratories
1.3.4 Physician Offices
1.4 Global Toxoplasmosis Testing Market Size & Forecast
1.5 Global Toxoplasmosis Testing Market Size and Forecast by Region
1.5.1 Global Toxoplasmosis Testing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Toxoplasmosis Testing Market Size by Region, (2016-2021)
1.5.3 North America Toxoplasmosis Testing Market Size and Prospect (2016-2026)
1.5.4 Europe Toxoplasmosis Testing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Toxoplasmosis Testing Market Size and Prospect (2016-2026)
1.5.6 South America Toxoplasmosis Testing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Toxoplasmosis Testing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Toxoplasmosis Testing Market Drivers
1.6.2 Toxoplasmosis Testing Market Restraints
1.6.3 Toxoplasmosis Testing Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Toxoplasmosis Testing Product and Solutions
2.1.4 Abbott Laboratories Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Affymetrix
2.2.1 Affymetrix Details
2.2.2 Affymetrix Major Business
2.2.3 Affymetrix Toxoplasmosis Testing Product and Solutions
2.2.4 Affymetrix Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Affymetrix Recent Developments and Future Plans
2.3 Bio-Rad Laboratories
2.3.1 Bio-Rad Laboratories Details
2.3.2 Bio-Rad Laboratories Major Business
2.3.3 Bio-Rad Laboratories Toxoplasmosis Testing Product and Solutions
2.3.4 Bio-Rad Laboratories Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.4 Beckman Coulter
2.4.1 Beckman Coulter Details
2.4.2 Beckman Coulter Major Business
2.4.3 Beckman Coulter Toxoplasmosis Testing Product and Solutions
2.4.4 Beckman Coulter Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Beckman Coulter Recent Developments and Future Plans
2.5 Biomerica
2.5.1 Biomerica Details
2.5.2 Biomerica Major Business
2.5.3 Biomerica Toxoplasmosis Testing Product and Solutions
2.5.4 Biomerica Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Biomerica Recent Developments and Future Plans
2.6 Cepheid
2.6.1 Cepheid Details
2.6.2 Cepheid Major Business
2.6.3 Cepheid Toxoplasmosis Testing Product and Solutions
2.6.4 Cepheid Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Cepheid Recent Developments and Future Plans
2.7 Biotest
2.7.1 Biotest Details
2.7.2 Biotest Major Business
2.7.3 Biotest Toxoplasmosis Testing Product and Solutions
2.7.4 Biotest Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Biotest Recent Developments and Future Plans
2.8 GenBio
2.8.1 GenBio Details
2.8.2 GenBio Major Business
2.8.3 GenBio Toxoplasmosis Testing Product and Solutions
2.8.4 GenBio Toxoplasmosis Testing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 GenBio Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Toxoplasmosis Testing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Toxoplasmosis Testing Players Market Share
3.2.2 Top 10 Toxoplasmosis Testing Players Market Share
3.2.3 Market Competition Trend
3.3 Toxoplasmosis Testing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Toxoplasmosis Testing Revenue and Market Share by Type (2016-2021)
4.2 Global Toxoplasmosis Testing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Toxoplasmosis Testing Revenue Market Share by Application (2016-2021)
5.2 Toxoplasmosis Testing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Toxoplasmosis Testing Revenue by Type (2016-2026)
6.2 North America Toxoplasmosis Testing Revenue by Application (2016-2026)
6.3 North America Toxoplasmosis Testing Market Size by Country
6.3.1 North America Toxoplasmosis Testing Revenue by Country (2016-2026)
6.3.2 United States Toxoplasmosis Testing Market Size and Forecast (2016-2026)
6.3.3 Canada Toxoplasmosis Testing Market Size and Forecast (2016-2026)
6.3.4 Mexico Toxoplasmosis Testing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Toxoplasmosis Testing Revenue by Type (2016-2026)
7.2 Europe Toxoplasmosis Testing Revenue by Application (2016-2026)
7.3 Europe Toxoplasmosis Testing Market Size by Country
7.3.1 Europe Toxoplasmosis Testing Revenue by Country (2016-2026)
7.3.2 Germany Toxoplasmosis Testing Market Size and Forecast (2016-2026)
7.3.3 France Toxoplasmosis Testing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Toxoplasmosis Testing Market Size and Forecast (2016-2026)
7.3.5 Russia Toxoplasmosis Testing Market Size and Forecast (2016-2026)
7.3.6 Italy Toxoplasmosis Testing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Toxoplasmosis Testing Revenue by Type (2016-2026)
8.2 Asia-Pacific Toxoplasmosis Testing Revenue by Application (2016-2026)
8.3 Asia-Pacific Toxoplasmosis Testing Market Size by Region
8.3.1 Asia-Pacific Toxoplasmosis Testing Revenue by Region (2016-2026)
8.3.2 China Toxoplasmosis Testing Market Size and Forecast (2016-2026)
8.3.3 Japan Toxoplasmosis Testing Market Size and Forecast (2016-2026)
8.3.4 South Korea Toxoplasmosis Testing Market Size and Forecast (2016-2026)
8.3.5 India Toxoplasmosis Testing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Toxoplasmosis Testing Market Size and Forecast (2016-2026)
8.3.7 Australia Toxoplasmosis Testing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Toxoplasmosis Testing Revenue by Type (2016-2026)
9.2 South America Toxoplasmosis Testing Revenue by Application (2016-2026)
9.3 South America Toxoplasmosis Testing Market Size by Country
9.3.1 South America Toxoplasmosis Testing Revenue by Country (2016-2026)
9.3.2 Brazil Toxoplasmosis Testing Market Size and Forecast (2016-2026)
9.3.3 Argentina Toxoplasmosis Testing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Toxoplasmosis Testing Revenue by Type (2016-2026)
10.2 Middle East & Africa Toxoplasmosis Testing Revenue by Application (2016-2026)
10.3 Middle East & Africa Toxoplasmosis Testing Market Size by Country
10.3.1 Middle East & Africa Toxoplasmosis Testing Revenue by Country (2016-2026)
10.3.2 Turkey Toxoplasmosis Testing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Toxoplasmosis Testing Market Size and Forecast (2016-2026)
10.3.4 UAE Toxoplasmosis Testing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Toxoplasmosis Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Toxoplasmosis Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Toxoplasmosis Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Toxoplasmosis Testing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Toxoplasmosis Testing Revenue Market Share by Region (2021-2026)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Toxoplasmosis Testing Product and Solutions
Table 9. Abbott Laboratories Toxoplasmosis Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Affymetrix Corporate Information, Head Office, and Major Competitors
Table 11. Affymetrix Major Business
Table 12. Affymetrix Toxoplasmosis Testing Product and Solutions
Table 13. Affymetrix Toxoplasmosis Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Bio-Rad Laboratories Major Business
Table 16. Bio-Rad Laboratories Toxoplasmosis Testing Product and Solutions
Table 17. Bio-Rad Laboratories Toxoplasmosis Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 19. Beckman Coulter Major Business
Table 20. Beckman Coulter Toxoplasmosis Testing Product and Solutions
Table 21. Beckman Coulter Toxoplasmosis Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Biomerica Corporate Information, Head Office, and Major Competitors
Table 23. Biomerica Major Business
Table 24. Biomerica Toxoplasmosis Testing Product and Solutions
Table 25. Biomerica Toxoplasmosis Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Cepheid Corporate Information, Head Office, and Major Competitors
Table 27. Cepheid Major Business
Table 28. Cepheid Toxoplasmosis Testing Product and Solutions
Table 29. Cepheid Toxoplasmosis Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Biotest Corporate Information, Head Office, and Major Competitors
Table 31. Biotest Major Business
Table 32. Biotest Toxoplasmosis Testing Product and Solutions
Table 33. Biotest Toxoplasmosis Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. GenBio Corporate Information, Head Office, and Major Competitors
Table 35. GenBio Major Business
Table 36. GenBio Toxoplasmosis Testing Product and Solutions
Table 37. GenBio Toxoplasmosis Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Toxoplasmosis Testing Revenue (USD Million) by Players (2019-2021)
Table 39. Global Toxoplasmosis Testing Revenue Share by Players (2019-2021)
Table 40. Breakdown of Toxoplasmosis Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Toxoplasmosis Testing Players Head Office, Products and Services Provided
Table 42. Toxoplasmosis Testing Mergers & Acquisitions in the Past Five Years
Table 43. Toxoplasmosis Testing New Entrants and Expansion Plans
Table 44. Global Toxoplasmosis Testing Revenue (USD Million) by Type (2016-2021)
Table 45. Global Toxoplasmosis Testing Revenue Share by Type (2016-2021)
Table 46. Global Toxoplasmosis Testing Revenue Forecast by Type (2021-2026)
Table 47. Global Toxoplasmosis Testing Revenue by Application (2016-2021)
Table 48. Global Toxoplasmosis Testing Revenue Forecast by Application (2021-2026)
Table 49. North America Toxoplasmosis Testing Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Toxoplasmosis Testing Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Toxoplasmosis Testing Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Toxoplasmosis Testing Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Toxoplasmosis Testing Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Toxoplasmosis Testing Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Toxoplasmosis Testing Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Toxoplasmosis Testing Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Toxoplasmosis Testing Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Toxoplasmosis Testing Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Toxoplasmosis Testing Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Toxoplasmosis Testing Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Toxoplasmosis Testing Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Toxoplasmosis Testing Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Toxoplasmosis Testing Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Toxoplasmosis Testing Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Toxoplasmosis Testing Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Toxoplasmosis Testing Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Toxoplasmosis Testing Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Toxoplasmosis Testing Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Toxoplasmosis Testing Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Toxoplasmosis Testing Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Toxoplasmosis Testing Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Toxoplasmosis Testing Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Toxoplasmosis Testing Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Toxoplasmosis Testing Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Toxoplasmosis Testing Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Toxoplasmosis Testing Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Toxoplasmosis Testing Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Toxoplasmosis Testing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Toxoplasmosis Testing Picture
Figure 2. Global Toxoplasmosis Testing Revenue Market Share by Type in 2020
Figure 3. Testing Equipment
Figure 4. Reagent Consumables
Figure 5. Toxoplasmosis Testing Revenue Market Share by Application in 2020
Figure 6. Hospitals Picture
Figure 7. Commercial Or Private Laboratories Picture
Figure 8. Physician Offices Picture
Figure 9. Global Toxoplasmosis Testing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Toxoplasmosis Testing Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Toxoplasmosis Testing Revenue Market Share by Region (2016-2026)
Figure 12. Global Toxoplasmosis Testing Revenue Market Share by Region in 2020
Figure 13. North America Toxoplasmosis Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Toxoplasmosis Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Toxoplasmosis Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Toxoplasmosis Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Toxoplasmosis Testing Market Drivers
Figure 18. Toxoplasmosis Testing Market Restraints
Figure 19. Toxoplasmosis Testing Market Trends
Figure 20. Abbott Laboratories Recent Developments and Future Plans
Figure 21. Affymetrix Recent Developments and Future Plans
Figure 22. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 23. Beckman Coulter Recent Developments and Future Plans
Figure 24. Biomerica Recent Developments and Future Plans
Figure 25. Cepheid Recent Developments and Future Plans
Figure 26. Biotest Recent Developments and Future Plans
Figure 27. GenBio Recent Developments and Future Plans
Figure 29. Global Toxoplasmosis Testing Revenue Share by Players in 2020
Figure 30. Toxoplasmosis Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 31. Global Top 3 Players Toxoplasmosis Testing Revenue Market Share in 2020
Figure 32. Global Top 10 Players Toxoplasmosis Testing Revenue Market Share in 2020
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 34. Global Toxoplasmosis Testing Revenue Share by Type in 2020
Figure 35. Global Toxoplasmosis Testing Market Share Forecast by Type (2021-2026)
Figure 36. Global Toxoplasmosis Testing Revenue Share by Application in 2020
Figure 37. Global Toxoplasmosis Testing Market Share Forecast by Application (2021-2026)
Figure 38. North America Toxoplasmosis Testing Sales Market Share by Type (2016-2026)
Figure 39. North America Toxoplasmosis Testing Sales Market Share by Application (2016-2026)
Figure 40. North America Toxoplasmosis Testing Revenue Market Share by Country (2016-2026)
Figure 41. United States Toxoplasmosis Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Toxoplasmosis Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Toxoplasmosis Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Toxoplasmosis Testing Sales Market Share by Type (2016-2026)
Figure 45. Europe Toxoplasmosis Testing Sales Market Share by Application (2016-2026)
Figure 46. Europe Toxoplasmosis Testing Revenue Market Share by Country (2016-2026)
Figure 47. Germany Toxoplasmosis Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Toxoplasmosis Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Toxoplasmosis Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Toxoplasmosis Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Toxoplasmosis Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Toxoplasmosis Testing Sales Market Share by Type (2016-2026)
Figure 53. Asia-Pacific Toxoplasmosis Testing Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Toxoplasmosis Testing Revenue Market Share by Region (2016-2026)
Figure 55. China Toxoplasmosis Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Toxoplasmosis Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South Korea Toxoplasmosis Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Toxoplasmosis Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Toxoplasmosis Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Toxoplasmosis Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Toxoplasmosis Testing Sales Market Share by Type (2016-2026)
Figure 62. South America Toxoplasmosis Testing Sales Market Share by Application (2016-2026)
Figure 63. South America Toxoplasmosis Testing Revenue Market Share by Country (2016-2026)
Figure 64. Brazil Toxoplasmosis Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Argentina Toxoplasmosis Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Middle East and Africa Toxoplasmosis Testing Sales Market Share by Type (2016-2026)
Figure 67. Middle East and Africa Toxoplasmosis Testing Sales Market Share by Application (2016-2026)
Figure 68. Middle East and Africa Toxoplasmosis Testing Revenue Market Share by Country (2016-2026)
Figure 69. Turkey Toxoplasmosis Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Saudi Arabia Toxoplasmosis Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. UAE Toxoplasmosis Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source
世界のトキソプラズマ症検査市場規模・現状・予測（2021年-2027年） The term toxoplasmosis refers to the infectious disease caused by the parasite Toxoplasma gondii. It may cause acute or chronic infection. Currently, North America dominates the global toxoplasmosis testing market, followed by Europe. This is due to the rising prevalence of infectious diseases and i…- 世界のトキソプラズマ症治療薬市場 2021：企業別、地域別、種類・用途別 The Drugs for Toxoplasmosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界のゾリンジャー-エリソン症候群検査市場規模・現状・予測（2021年-2027年） Zollinger-Ellison syndrome is a rare condition in which one or more tumors form in your pancreas or the upper part of your small intestine (duodenum). Market Analysis and Insights: Global Zollinger - Ellison Syndrome Testing Market The global Zollinger - Ellison Syndrome Testing market size is proj…
- 世界の血液感染検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Blood Infection Testing Market The global Blood Infection Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…
- 世界の菌血症検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bloodstream Infection Testing Market The global Bloodstream Infection Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…